Medical Law Research This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

• Default
• News
• Research
• Blogs
• Podcasts
• Video
• Events
• Funding
• Alerts
• Clinical Trials
• Forums
• Top 20

Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies
Nanomaterials have the promise of revolutionizing current treatment and diagnosis of diseases, which has led to 33 nanotherapeutics drugs currently on the market and many more in various stages of clinical trials. With an increasing number of products available and in development, along with the unique, emergent properties of the nanoparticle therapeutics themselves, regulatory agencies are now faced with decisions regarding the regulation of such novel technologies. Regulatory guidance, particularly in pre‐clinical stages, has the potential to facilitate quick and safe development of these novel materials, but new regul...
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Melissa A. Maurer‐Jones, Christy L. Haynes Source Type: research

What Is Unique About Nanomedicine? The Significance of the Mesoscale
Unlike drugs and medical devices, for which long standing and continuously improving quality assurance/quality control infrastructures exist, many nano‐based products lack well‐defined standards that are useful to manufacturers and regulators. Inherent variabilities in nanoparticle sizes and shapes, their large surface‐to‐volume ratios, and their mesoscale interactions with subcellular structures, suggest new complexities and challenges that must be met before widespread application of nanomedicines can be expected.
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: George Khushf, Ronald A. Siegel Source Type: research

A Portrait of Nanomedicine and Its Bioethical Implications
This review addresses the current and future potential of nanomedicine, and its ethical considerations within the comprehensive framework of the four dimensions of medical ethics: Beneficence, Non‐Maleficence, Respect, and Justice. From this perspective, the ethical considerations for nanomedicine are not novel, but have been addressed by precedents throughout the history of medicine. While these ethical challenges are not unique to nanomedicine, some require additional consideration, given the envisioned pervasive impact of nanomedicine on society.
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Rebecca M. Hall, Tong Sun, Mauro Ferrari Source Type: research

An Empirical Examination of the Current State of Publically Available Nanotechnology Guidance Materials
As part of “Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight,” an empirical search was conducted to identify publicly available resources that guided understanding about human subjects issues in nanomedicine or nanotechnology including policy statements, guidance documents, or consent forms. The authors conducted 5,083 internet searches and analyzed 175 documents. Results show that very little guidance is publicly available and most documents focused on occupational and environmental concerns.
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Laura Fleege, Frances Lawrenz Source Type: research

Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field
The nanomedicine field is fast evolving toward complex, “active,” and interactive formulations. Like many emerging technologies, nanomedicine raises questions of how human subjects research (HSR) should be conducted and the adequacy of current oversight, as well as how to integrate concerns over occupational, bystander, and environmental exposures. The history of oversight for HSR investigating emerging technologies is a patchwork quilt without systematic justification of when ordinary oversight for HSR is enough versus when added oversight is warranted. Nanomedicine HSR provides an occasion to think systematically abo...
Source: The Journal of Law, Medicine and Ethics - January 3, 2013 Category: Medical Law Authors: Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nan Source Type: research

The relationship between psychopathy and crime-related amnesia.
The objective of this study was to investigate whether levels of psychopathy predicted claims of crime-related amnesia. Different characteristics of psychopathy were based on the factor structure of the self-report questionnaire Psychopathic Personality Inventory (PPI). Crime-related amnesia claims were scored from inmates (N=31) criminal file records. Results demonstrated that claims of crime-related amnesia were more frequently reported by individuals scoring high on impulsive antisocial psychopathy traits. Furthermore, offenders who claimed crime-related amnesia reported lower levels of instrumental/proactive aggression...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Cima M, Van Oorsouw K Tags: Int J Law Psychiatry Source Type: research

Homeward bound or bound for a home? Assessing the capacity of dementia patients to make decisions about hospital discharge: Comparing practice with legal standards.
CONCLUSIONS: We conclude by suggesting that more specific legal standards are required when assessing capacity in this particular context. PMID: 23187119 [PubMed - in process]
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Emmett C, Poole M, Bond J, Hughes JC Tags: Int J Law Psychiatry Source Type: research

Child homicide by parents in Chile: A gender-based study and analysis of post-filicide attempted suicide.
DISCUSSION: Analysis of the data revealed differences between filicidal men and women with regard to demographic characteristics, but the differences in psychopathological factors and variables that were related to the crimes were minor. A comparative analysis of the filicide perpetrators based on post-crime suicide attempts did not find significant differences between groups. In addition, a predictive analysis of suicidal behavior concludes that individual variables (such as the level of education of the person committing infanticide and the method used for the homicide) are not sufficient to explain the entire phenomenon...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Benítez-Borrego S, Guàrdia-Olmos J, Aliaga-Moore A Tags: Int J Law Psychiatry Source Type: research

Histories of childhood victimization and subsequent mental health problems, substance use, and sexual victimization for a sample of incarcerated women in the US.
This article ends with a discussion about prisons' role in providing treatment for women prisoners and basing this treatment on women's trajectories to prison, which disproportionately include childhood victimization and subsequent mental health and substance use problems. PMID: 23196054 [PubMed - in process]
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Tripodi SJ, Pettus-Davis C Tags: Int J Law Psychiatry Source Type: research

Mental health in juvenile judges' decision-making: Review of literature.
DISCUSSION: Mental health aspects seem to be associated with the decision-making process of the juvenile judge. Future research should further examine the association between these aspects and the decision of the juvenile judge, particularly in the subgroup of juvenile offenders with mental disorders. PMID: 23218170 [PubMed - in process]
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Cappon L, Vander Laenen F Tags: Int J Law Psychiatry Source Type: research

Psychopathy and behavior problems: A comparison of incarcerated male and female juvenile delinquents.
The objective of the present study was to compare incarcerated male and female juvenile offenders regarding psychopathic traits, behavior problems, psychopathy taxon, conduct disorder, self-reported delinquent behavior, and crime seriousness. Within a total forensic sample of 261 detainee participants, subdivided in a male group (n=217) and a female group (n=44), statistically significant differences were found. Female juvenile offenders show less callous-unemotional traits, more emotional symptoms, more prosocial behaviors, less self-reported delinquent behavior, and lower crime seriousness. Conduct disorder prevalence wa...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Pechorro PS, Vieira DN, Poiares CA, Vieira RX, Marôco J, Neves S, Nunes C Tags: Int J Law Psychiatry Source Type: research

Misinformation can influence memory for recently experienced, highly stressful events.
Abstract A large body of research has demonstrated that exposure to misinformation can lead to distortions in human memory for genuinely experienced objects or people. The current study examined whether misinformation could affect memory for a recently experienced, personally relevant, highly stressful event. In the present study we assessed the impact of misinformation on memory in over 800 military personnel confined in the stressful, mock POW camp phase of Survival School training. Misinformation introduced after the negatively affected memory for the details of the event (such as the presence of glasses or weap...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Morgan CA, Southwick S, Steffian G, Hazlett GA, Loftus EF Tags: Int J Law Psychiatry Source Type: research

Attitudes among judiciary and junior clerks toward the survivors of childhood sexual abuse.
Abstract Childhood sexual abuse is a growing concern throughout the world, although the legal sequelae of this phenomenon are frequently neglected. We aimed to reveal and compare the attitudes of judiciary and junior clerks toward sexually abused children that might contribute to these sequelae. We divided 302 study participants into two groups of judiciary members and junior clerks. All the participants were asked to anonymously complete a questionnaire about stigmatization, including questions assessing social distance, dangerousness and skillfulness. In their responses, 51.2% of the judiciary and 64.0% of the ju...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Berber G, Karapirli M, Kantarci N, Kandemir E, Varkal MD, Sahin E, Emül M Tags: Int J Law Psychiatry Source Type: research

Fetal alcohol spectrum disorder: Can diminished responsibility diminish criminal behaviour?
Abstract This text examines how current scientific knowledge has the potential of fulfilling one of the major functions of the criminal justice system. Scientific knowledge should be used to ensure that the criminal justice system's functioning results in maximizing societal protection and crime reduction. Abnormal states of the mind contribute to criminal behaviour and are considered in exculpatory defences. The failure of the long standing insanity defence and its utility among cognitively impaired offenders, provided impetus to this work. In estimating the success rates (or lack thereof) of raised defences for t...
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Mela M, Luther G Tags: Int J Law Psychiatry Source Type: research

Five years after implementation: A review of the Irish Mental Health Act 2001.
CONCLUSIONS: The MHA 2001 has brought the practice of involuntary admission further into line with international standards. However, five years after the implementation of the Act international guidelines and practice have highlighted areas in need of further reform, including capacity legislation and consideration of advance directives and community treatment orders. Further research is also lacking on caregivers' or family members' perceptions of the MHA 2001. PMID: 23274178 [PubMed - in process]
Source: International Journal of Law and Psychiatry - January 1, 2013 Category: Medical Law Authors: Ramsay H, Roche E, O'Donoghue B Tags: Int J Law Psychiatry Source Type: research

Legislative Status of the Biofuels Tax Credit
Biotechnology Law Report , Vol. 0, No. 0.
Source: Biotechnology Law Report - December 31, 2012 Category: Medical Law Tags: article Source Type: research

Alcohol-intoxicated patients at admission room - analysis of legal aspects of rendered medical services.
Abstract Current legal regulations do not explicitly state whether the doctor should or should not ignore the patient's refusal to be provided with medical services when such refusal is given by the patients who is temporarily unable to take conscious decisions. The fact that there is no clear jurisdiction over the issue makes the relation between doctor and patient legally complicated. The doctor has no doubts whether he/she should or should not initiate the medical procedure when the patient clearly expresses the declaration of will, in which either refusal or consent is given to be provided with medical care. Ho...
Source: Annals of Agricultural and Environmental Medicine : AAEM - December 31, 2012 Category: Environmental Health Authors: Zajdel J, Zajdel R, Dziki A, Wallner G Tags: Ann Agric Environ Med Source Type: research

Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
Intellectual property is associated with the creative work needed to design clinical trials. Two approaches have developed to protect the intellectual property associated with multicentre trial protocols prior to site initiation.The 'open access' approach involves publishing the protocol, permitting easy access to the complete protocol. The main advantages of the open access approach are that the protocol is freely available to all stakeholders, permitting them to discuss the protocol widely with colleagues, assess the quality and rigour of the protocol, determine the feasibility of conducting the trial at their centre, an...
Source: Trials - December 27, 2012 Category: Journals (General) Authors: Sue RossLaura MageeMark WalkerStephen Wood Source Type: research

Preliminary Ruling of the Court of Justice of the European Union in Neurim Pharmaceuticals (1991) Ltd. v. Comptroller–General of Patents on Supplementary Protection Certificates in Europe
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 565-571.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Drug Companies Filing Citizen Petitions?
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 592-593.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Canada Cancels Pfizer's Viagra Patent
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 593-593.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

PhRMA Files Amicus Brief in K-Dur Case; DOCUMENT: Merck & Co., Inc. v. Louisiana Wholesale Drug Company, Inc., et al. (In the Supreme Court of the United States)
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 592-592.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Medecins sans Frontiers Posts Tool to Challenge “Unwarranted” Drug Patents
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 592-592.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

FTC Argues That Agreements Between Patent Holders and Generics Companies Are Anti-competitive
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 590-590.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

European Patent Court to Be Divided Among Three Countries
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 590-590.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

EMA Charges Roche Withheld Adverse Effects Data
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 582-582.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

ACLU, PUBPAT Want Certiorari in Myriad Case; DOCUMENT: The Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al. (In the Supreme Court of the United States)
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 591-591.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Is an OncoMouse Patent Still in Effect?
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 592-592.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Inviting Bids to Become a Preferred Supplier Does Not Violate Patents in Europe
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 590-590.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

India Revokes Pfizer's Cancer Drug Patent; Finds Lack of Inventive Step; Is Cost Real Reason?
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 591-591.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Fast Track Products More Likely to Have Serious Adverse Effects Than Those Reviewed by Standard Procedures
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 580-580.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

In re Peter Droge, Nicole Christ, and Elke Lorbach; (United States Court of Appeals for the Federal Circuit); Appeal from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 625-627.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Abbott GmbH & Co., KG; Abbott Bioresearch Center, Inc.; and Abbott Biotechnology Ltd. v. Centocor Ortho Biotech, Inc., and Centocor Biologics, Inc. [excerpts]; (United States District Court - District of Massachusetts); Amended Memorandum and Order on Cross-Motions for Summary Judgment
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 628-656.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Nobel Laureate Warns About Unsupported, Possibly Dangerous, Uses of Stem Cells
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 580-580.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Merck & Co., Inc. v. Louisiana Wholesale Drug Company, Inc., et al.; (Supreme Court of the United States); On Petition for a Writ of Certiorari to the U.S. Court of Appeals for the Third Circuit Brief of Pharmaceutical Research and Manufacturers of America as Amicus Curiae in Support of Petitioner
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 619-624.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

NICE Will Review Products Before They Are Marketed
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 581-581.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

In re Rigel Pharmaceuticals, Inc. Securities Litigation; (U.S. Court of Appeals for the Ninth Circuit)
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 595-606.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Withdrawal of Ineffective Generic Drug Creates Disturbance
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 581-581.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Report on Whole-Genome Sequencing Concerns Issued; Presidential Commission Worries About Privacy
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 579-579.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

The Association for Molecular Pathology, et al., Petitioners, v. Myriad Genetics, Inc., et al., Respondents; (Supreme Court of the United States); On Petition for a Writ of Certiorari to the U.S. Court of Appeals for the Federal Circuit
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 607-618.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

FDA Approves New Indication for Humira
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 578-579.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

WSJ Law Blog Complains of “Criminalization of the Practice of Law”
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 579-580.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

EEF Wants to Stop Police from Collecting DNA from Arrested Persons
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 579-579.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Biologics Manufacturing Plant Opens in China; Will Satisfy U.S. and European Standards
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 581-582.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

ReNeuron Applies for Clinical Trial Permission
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 589-589.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Advice for FDA on Regulatory Path for Cell-Based Therapies
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 581-581.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Canada May Not Approve Generic Versions of OxyContin
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 578-578.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Europe Approves First Gene Therapy Product
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 578-578.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

New Patents and Allowances
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 593-594.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research

Top Patent Cases Related to Biotechnology
Biotechnology Law Report Dec 2012, Vol. 31, No. 6: 572-577.
Source: Biotechnology Law Report - December 17, 2012 Category: Medical Law Tags: article Source Type: research